<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6FA20B99-5C90-4063-96CD-82BC7720F719"><gtr:id>6FA20B99-5C90-4063-96CD-82BC7720F719</gtr:id><gtr:name>Intellikine, Inc.</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FFFE8E49-286F-484C-A2B7-74856B015E34"><gtr:id>FFFE8E49-286F-484C-A2B7-74856B015E34</gtr:id><gtr:name>Vertex Pharmaceuticals</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2A2C4471-6207-410F-AF5E-A4074808D65B"><gtr:id>2A2C4471-6207-410F-AF5E-A4074808D65B</gtr:id><gtr:name>Miltenyi Biotec GmBH</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D"><gtr:id>DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D</gtr:id><gtr:name>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8C6B0047-ADBF-41FE-B785-562AB56AF2A8"><gtr:id>8C6B0047-ADBF-41FE-B785-562AB56AF2A8</gtr:id><gtr:name>University of Colorado Boulder</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2F6044B9-9BC3-4ABA-9115-6AA15854A44A"><gtr:id>2F6044B9-9BC3-4ABA-9115-6AA15854A44A</gtr:id><gtr:name>University of Basel</gtr:name><gtr:address><gtr:line1>Petersplatz 1</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/17BF6965-68C3-4560-8BC2-28AC2D489890"><gtr:id>17BF6965-68C3-4560-8BC2-28AC2D489890</gtr:id><gtr:name>University of Virginia</gtr:name><gtr:address><gtr:line1>P.O. Box 3818</gtr:line1><gtr:postCode>22903</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/040001EB-7CD7-4B8C-998C-7097FA7B9B98"><gtr:id>040001EB-7CD7-4B8C-998C-7097FA7B9B98</gtr:id><gtr:name>Mount Sinai Hospital (Canada)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68BE577-6C17-48CE-B65C-24C477BB8AE9"><gtr:id>E68BE577-6C17-48CE-B65C-24C477BB8AE9</gtr:id><gtr:name>Yeshiva University</gtr:name><gtr:address><gtr:line1>500 West 185th Street</gtr:line1><gtr:postCode>10033</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/65CA66B5-6FE8-4FD7-9233-FBCF31BFD4B2"><gtr:id>65CA66B5-6FE8-4FD7-9233-FBCF31BFD4B2</gtr:id><gtr:name>Cornell University</gtr:name><gtr:address><gtr:line1>410 Thurston Ave</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/335DFBB5-7BB6-448B-AFD4-1904C4D9A808"><gtr:id>335DFBB5-7BB6-448B-AFD4-1904C4D9A808</gtr:id><gtr:name>Vlaams Instituut Biotechnologie (VIB)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB"><gtr:id>7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB</gtr:id><gtr:name>University of Geneva</gtr:name><gtr:address><gtr:line1>University of Geneva</gtr:line1><gtr:line2>30 Quai Ernest-Ansemet</gtr:line2><gtr:postCode>CH-1211</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/53A8F4B4-EBD0-4199-B24B-B5008112311D"><gtr:id>53A8F4B4-EBD0-4199-B24B-B5008112311D</gtr:id><gtr:name>Guy's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C1F2272D-CAD4-4FE8-97EF-1D668F0FD07A"><gtr:id>C1F2272D-CAD4-4FE8-97EF-1D668F0FD07A</gtr:id><gtr:name>Texas A &amp; M University</gtr:name><gtr:address><gtr:line1>College Station</gtr:line1><gtr:line4>Bryan</gtr:line4><gtr:line5>TX 77843-3258</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7111EF10-B5DF-4DA9-8324-2B55178F7871"><gtr:id>7111EF10-B5DF-4DA9-8324-2B55178F7871</gtr:id><gtr:name>Uni of Illinois at Urbana Champaign</gtr:name><gtr:address><gtr:line1>Admissions and Records</gtr:line1><gtr:line2>901 West Illinois Street</gtr:line2><gtr:postCode>61801</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6FA20B99-5C90-4063-96CD-82BC7720F719"><gtr:id>6FA20B99-5C90-4063-96CD-82BC7720F719</gtr:id><gtr:name>Intellikine, Inc.</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FFFE8E49-286F-484C-A2B7-74856B015E34"><gtr:id>FFFE8E49-286F-484C-A2B7-74856B015E34</gtr:id><gtr:name>Vertex Pharmaceuticals</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2A2C4471-6207-410F-AF5E-A4074808D65B"><gtr:id>2A2C4471-6207-410F-AF5E-A4074808D65B</gtr:id><gtr:name>Miltenyi Biotec GmBH</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D"><gtr:id>DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D</gtr:id><gtr:name>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8C6B0047-ADBF-41FE-B785-562AB56AF2A8"><gtr:id>8C6B0047-ADBF-41FE-B785-562AB56AF2A8</gtr:id><gtr:name>University of Colorado Boulder</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2F6044B9-9BC3-4ABA-9115-6AA15854A44A"><gtr:id>2F6044B9-9BC3-4ABA-9115-6AA15854A44A</gtr:id><gtr:name>University of Basel</gtr:name><gtr:address><gtr:line1>Petersplatz 1</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/17BF6965-68C3-4560-8BC2-28AC2D489890"><gtr:id>17BF6965-68C3-4560-8BC2-28AC2D489890</gtr:id><gtr:name>University of Virginia</gtr:name><gtr:address><gtr:line1>P.O. Box 3818</gtr:line1><gtr:postCode>22903</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/040001EB-7CD7-4B8C-998C-7097FA7B9B98"><gtr:id>040001EB-7CD7-4B8C-998C-7097FA7B9B98</gtr:id><gtr:name>Mount Sinai Hospital (Canada)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68BE577-6C17-48CE-B65C-24C477BB8AE9"><gtr:id>E68BE577-6C17-48CE-B65C-24C477BB8AE9</gtr:id><gtr:name>Yeshiva University</gtr:name><gtr:address><gtr:line1>500 West 185th Street</gtr:line1><gtr:postCode>10033</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/65CA66B5-6FE8-4FD7-9233-FBCF31BFD4B2"><gtr:id>65CA66B5-6FE8-4FD7-9233-FBCF31BFD4B2</gtr:id><gtr:name>Cornell University</gtr:name><gtr:address><gtr:line1>410 Thurston Ave</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/335DFBB5-7BB6-448B-AFD4-1904C4D9A808"><gtr:id>335DFBB5-7BB6-448B-AFD4-1904C4D9A808</gtr:id><gtr:name>Vlaams Instituut Biotechnologie (VIB)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB"><gtr:id>7DB68CCC-DD52-4CCA-AFFF-13BADAE898FB</gtr:id><gtr:name>University of Geneva</gtr:name><gtr:address><gtr:line1>University of Geneva</gtr:line1><gtr:line2>30 Quai Ernest-Ansemet</gtr:line2><gtr:postCode>CH-1211</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/53A8F4B4-EBD0-4199-B24B-B5008112311D"><gtr:id>53A8F4B4-EBD0-4199-B24B-B5008112311D</gtr:id><gtr:name>Guy's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1F2272D-CAD4-4FE8-97EF-1D668F0FD07A"><gtr:id>C1F2272D-CAD4-4FE8-97EF-1D668F0FD07A</gtr:id><gtr:name>Texas A &amp; M University</gtr:name><gtr:address><gtr:line1>College Station</gtr:line1><gtr:line4>Bryan</gtr:line4><gtr:line5>TX 77843-3258</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7111EF10-B5DF-4DA9-8324-2B55178F7871"><gtr:id>7111EF10-B5DF-4DA9-8324-2B55178F7871</gtr:id><gtr:name>Uni of Illinois at Urbana Champaign</gtr:name><gtr:address><gtr:line1>Admissions and Records</gtr:line1><gtr:line2>901 West Illinois Street</gtr:line2><gtr:postCode>61801</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CA83E080-E975-4FE6-AB59-F40EEF323639"><gtr:id>CA83E080-E975-4FE6-AB59-F40EEF323639</gtr:id><gtr:firstName>Roger</gtr:firstName><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105184308"><gtr:id>6B7FC9E4-B5C8-4B04-B791-808F07284D73</gtr:id><gtr:title>Structural studies of phosphoinositide signalling and intracellular sorting</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105184308</gtr:grantReference><gtr:abstractText>Mammalian cells have a complex regulation that enables them to respond to growth factors, neurotransmitters and hormones. However, they also have cell-intrinsic responses to starvation and other environmental stresses. We are determining structures and dynamics of the cellular machines that integrate these cues to regulate cell responses. Lipid membranes partition organelles within cells and they help organise these responses. An important component of the work we do concerns how cellular machines interact with these membranes and how the shape and composition of the membranes determine the activity of these molecular machines. We are using the structures and dynamics of these machines to contribute to development of pharmaceuticals that may be useful in treating cancer, inflammation, diabetes and ageing.</gtr:abstractText><gtr:technicalSummary>Eukaryotic cells have evolved a number of mechanisms to respond to environmental stress. These stress responses are tempered by growth factors and other signals from surrounding cells in multicellular organisms. Our research programme involves the mechanisms whereby these cellular signals are coupled to regulation of anabolic and catabolic processes in mammalian cells. Phosphoinositide 3-kinases (PI3Ks) modify lipid membranes and the modified phospholipids produced by the enzymes serve as second messengers and sorting signals in eukaryotic cells. The PI3Ks are essential for cell response to environmental cues. Furthermore, PI3Ks are part of a larger family of kinases known as the PI3K-related kinases (PIKKs). We study the structures, dynamics and functions of PIKKs and related pathways in cellular signalling, sorting and stress responses. This has included almost all of the members of the PI3K family: class I PI3Ks activated by receptor tyrosine kinase and GPCRS, the primordial class III PI3K complex present in all eukaryotes, the golgi-associated PI4K, the PI3K related protein kinases target of rapamycin (TOR) and PIKKs such as ATM involved in DNA repair pathways. Each of these PIKKs is a regulatory nexus, and our work produces variants in which specific regulatory inputs of the large enzyme complexes are ablated without affecting other activities. These modified complexes provide tools to decipher cellular regulation in ways that would not be possible with other approaches. We use X-ray crystallography, cryo-electron microscopy (cryo-EM) and hydrogen-deuterium exchange mass spectrometry (HDX-MS) to marry structures with dynamics. In collaboration with our pharmaceutical partners, we are seeking to develop HDX-MS approaches to give better insight into conformational dynamics that could result in new therapeutic strategies. On-going efforts in the group concern the structural and dynamic basis of regulation of oncogenic PI3Ks, autophagic PI3K complexes, integration of amino acid and growth factor sensing in the PI3K pathway, regulation of ribosomes in response to amino acid starvation and DNA damage repair.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1997-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>9765276</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Research and Development AstraZeneca</gtr:department><gtr:description>HDX-MS to probe enzyme regulation and develop novel inhibitors of PI3Ks</gtr:description><gtr:id>C8047CAD-6A76-45B4-BE25-81C99D467C36</gtr:id><gtr:impact>There have not been any reportable outcomes yet</gtr:impact><gtr:outcomeId>56dc0aba0e4fa1.83637641-1</gtr:outcomeId><gtr:partnerContribution>We meet regularly with our partners to discuss HDX-MS data acquisition and processing. We have participated in training postdocs in our partner organisation.</gtr:partnerContribution><gtr:piContribution>We are using HDX-MS methods to develop inhibitors that prevent activation of PI3K complexes on membranes. In order to optimise this process, we are employing new MS fragmentation techniques.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>The structure of PI3K alpha</gtr:description><gtr:id>03D60548-47CE-4043-9C25-C636E374E921</gtr:id><gtr:impact>This resulted in the publication f the structure and our conclusions in the journal Science. Pubmed id 17626883</gtr:impact><gtr:outcomeId>0083D6D09FD-1</gtr:outcomeId><gtr:partnerContribution>Over the period of the collaboration, we have discussed directions important for development of PI3K inhibitors</gtr:partnerContribution><gtr:piContribution>We expressed, purified and crystallised the core of the p110 alpha/p85 complex. We determined the structure of the adaptor-binding domain of p110 alpha in a complex with the iSH2 domain from p85 regulatory subunit.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eberhard Karls University of Tubingen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Regulation of class IB PI3Ks</gtr:description><gtr:id>F0F0D2F8-E044-48B4-9369-193201ED1210</gtr:id><gtr:impact>Three publications, PUBMED IDS: 3211529, 24190998 and 26173259</gtr:impact><gtr:outcomeId>56dc3e4a7a9512.06465117-1</gtr:outcomeId><gtr:partnerContribution>They have provided lipidated Gbeta/gamma subunits expressed in SF9 cells</gtr:partnerContribution><gtr:piContribution>We have carried HDX-MS studies of class IB PI3Ks and determined their activities in vitro</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cryo-EM of ATM and ATR complexes</gtr:description><gtr:id>6F996312-5483-479F-AA80-43C41197E3B7</gtr:id><gtr:impact>No reportable outputs yet</gtr:impact><gtr:outcomeId>56dc18b5b21506.31706609-1</gtr:outcomeId><gtr:partnerContribution>Sjors is providing guidance for analysing cryo-EM data</gtr:partnerContribution><gtr:piContribution>We are determining structures of ATM and ATR-containing complexes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Structural studies of golgi-associated proteins</gtr:description><gtr:id>67BBAA03-AB67-42A8-9CEF-4B9F0B2D43CD</gtr:id><gtr:impact>One publication, PUBMED ID 14580338, Another in review.</gtr:impact><gtr:outcomeId>56dc1108f04af1.53970582-1</gtr:outcomeId><gtr:partnerContribution>They have helped us with assays of intracellular protein sorting.</gtr:partnerContribution><gtr:piContribution>We have helped researchers in Sean Munro's lab to determine structures of golgi-associated proteins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Cancer Institute</gtr:department><gtr:description>Developing activators of lipid kinases</gtr:description><gtr:id>D93F041E-27CB-4975-B082-EE247EBC96A8</gtr:id><gtr:impact>The collaboration has so far discovered a set of putative activators.</gtr:impact><gtr:outcomeId>58c15558e5d0a2.92741069-2</gtr:outcomeId><gtr:partnerContribution>AstraZeneca carried out a large-scale screen of a compound library using our assays. Our collaborators at UCL will be involved in using these inhibitors in various biological contexts.</gtr:partnerContribution><gtr:piContribution>We developed an assay to select for small molecules that would activate lipid kinases. We also will investigate the mechanism of activation using HDX-MS.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Structure and function of phosphoinositide kinases</gtr:description><gtr:id>CEFD6116-6052-4335-B5F0-C40DC4D4A22A</gtr:id><gtr:impact>Two publications: 15350214, 25495341</gtr:impact><gtr:outcomeId>56dc24eaa842a4.04614020-1</gtr:outcomeId><gtr:partnerContribution>They have provided the ptoein complexes for analysis</gtr:partnerContribution><gtr:piContribution>We have analysed the dynamics and membrane binding of phosphtidylinositol kinases, using HDX-MS</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Metabolic Science (IMS)</gtr:department><gtr:description>The molecular basis of SHORT syndrome</gtr:description><gtr:id>CD91704C-9FB9-4C1C-A121-EE5825482EB6</gtr:id><gtr:impact>No reprtable output yet</gtr:impact><gtr:outcomeId>56dc49a9b6fec8.63927153-1</gtr:outcomeId><gtr:partnerContribution>The Ph.D. student has cloned SHORT syndrome mutants, expressed them and assayed their activity</gtr:partnerContribution><gtr:piContribution>We have provided p110alpha complexes and trained a Ph.D. student in work with mutants of the enzyme</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Vlaams Instituut Biotechnologie (VIB)</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Nanobodies for structural studies</gtr:description><gtr:id>451DA7C5-BA0A-422A-AD81-F5BB8FDBE4F3</gtr:id><gtr:impact>One publication, 26450213</gtr:impact><gtr:outcomeId>56dc4b833bef86.62664821-1</gtr:outcomeId><gtr:partnerContribution>Jan Steyaert has provided nanobodies that bind to Vps34-containing complexes and complexes of a class IA PI3K</gtr:partnerContribution><gtr:piContribution>We have provided cross-linked PI3K-containing complexes for immunization</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Signalling</gtr:department><gtr:description>Structural and functional studies of PI3Ks</gtr:description><gtr:id>542118EA-8DAD-442D-97C9-D1025D34AC18</gtr:id><gtr:impact>Six publications, PUBMED IDS: 11090628 11136978 11684018 15581496 21362552 24136356</gtr:impact><gtr:outcomeId>56dc23576c2ac4.84584217-1</gtr:outcomeId><gtr:partnerContribution>They have assayed PI3K complexes in cells and mice</gtr:partnerContribution><gtr:piContribution>We have determined structures of PI3K-containing complexes and analysed their dynamics by HDX-MS. We have also characterised in vitro activitiies of these complexes</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Geneva</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Quantitative analysis of the effects of membrane curvatute on activity of Vps34 complexes</gtr:description><gtr:id>695B01AA-D2F6-4D71-AB63-4F4FB05C0B86</gtr:id><gtr:impact>No reportable output yet</gtr:impact><gtr:outcomeId>56dc43878789b8.13291480-1</gtr:outcomeId><gtr:partnerContribution>They have drawn lipid tubules to generate high-curvature structures on which to assay the Vps34 complexes</gtr:partnerContribution><gtr:piContribution>We have provided purified Vps34 complexes and assayed them as a function of vesicle size and lipid composition</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Biological inhibitors of cancers</gtr:description><gtr:id>F9941F0A-3A15-4B4F-A8DB-E516D9D04417</gtr:id><gtr:impact>Publication 17568777</gtr:impact><gtr:outcomeId>9672DF77E80-1</gtr:outcomeId><gtr:partnerContribution>Prof. Rabbitts has explored the use of biological inhibitors such as intracellular antibodies for inhibiting cancers.</gtr:partnerContribution><gtr:piContribution>We have assisted in determining structures of complexes of intracellular antibodies with the small G-protein Ras</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Albert Einstein College of Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Inhibition of oncogenic PI3Ks</gtr:description><gtr:id>1395BA44-E525-4DCF-B0B8-76A7917E1E9A</gtr:id><gtr:impact>Publication 17626883</gtr:impact><gtr:outcomeId>60A95DF98EC-1</gtr:outcomeId><gtr:partnerContribution>Prof. Backer has provided valuable expertise and reagents for expressing and characterising PI3Ks</gtr:partnerContribution><gtr:piContribution>We have determined the structures of class IA PI3Ks and used these structures to define mechanisms of oncogenesis by smatic mutations in these enzymes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Medical Sciences Division</gtr:department><gtr:description>Role of ESCRTs in archaea</gtr:description><gtr:id>56C1608E-7602-451D-9D56-59210C9CED5F</gtr:id><gtr:impact>Publication 19008417</gtr:impact><gtr:outcomeId>9CE3B3611CE-1</gtr:outcomeId><gtr:partnerContribution>Prof. Bell has been essential in determining the roles of ESCRT-related proteins in archaeal cells</gtr:partnerContribution><gtr:piContribution>We have determined the structures of complexes of ESCRT-replated proteins from archaeal cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Helen Diller Family Comprehensive Cancer Center</gtr:department><gtr:description>Development of isotype-specific PI3K inhibitors</gtr:description><gtr:id>564F44F3-4A0C-4271-AC4C-C8C2255A29D9</gtr:id><gtr:impact>Seven publications, PUBMED IDS: 16647110, 18849971, 20081827, 20154668, 20339072, 24876499, 26756197</gtr:impact><gtr:outcomeId>56dc4a826f38f7.63804496-1</gtr:outcomeId><gtr:partnerContribution>Kevsn Shokat has provided isotype-spefic inhibitors</gtr:partnerContribution><gtr:piContribution>We have provided structures of complexes of PI3Ks with inhibitors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Miltenyi Biotec GmBH</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Bioinformatics of ESCRT complexes</gtr:description><gtr:id>E44BE09E-6917-440F-A69F-4666C34603B2</gtr:id><gtr:impact>One publication, pubmed ID 22405001</gtr:impact><gtr:outcomeId>56dc2419e42e30.44512634-1</gtr:outcomeId><gtr:partnerContribution>Kay Hoffman identified a novel ESCRT-I subunit</gtr:partnerContribution><gtr:piContribution>We have determined the structure of ESCRT-containing complexes</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Merck Serono</gtr:department><gtr:description>Structure-based drug discovery for PI3K delta inhibitors</gtr:description><gtr:id>AA37BA73-941C-4352-8D4F-0DF06A538D64</gtr:id><gtr:impact>We published our conclusions regarding isotype-specific inhibitors of PI3K delta in Nature Chemical Biology. This is currently in press and tentatively scheduled for publication in February, 2010.</gtr:impact><gtr:outcomeId>7090C3CEC41-1</gtr:outcomeId><gtr:partnerContribution>We have extensive, ongoing discussions regarding important directions in designing PI3K inhbitors</gtr:partnerContribution><gtr:piContribution>We established protocols for expressing and purifying large quantities of phosphoinositide 3-kinase alpha and delta for structure-based drug discovery programmes. We crystallised and determned structures of a wide ranger of complexes of these enzymes with inhibitors designed by Serono and others. Using these structures, we established mechanisms that underpin one class of isotype-specific inhibitor.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cryo-electron microscopy of a TOR complex</gtr:description><gtr:id>B9AED5E5-C224-4ABF-97B5-B482EF301C7A</gtr:id><gtr:impact>One publication in press</gtr:impact><gtr:outcomeId>56dc12467a8997.32369771-1</gtr:outcomeId><gtr:partnerContribution>Dr. Vinothkumar has provided advice on cryo-EM, collected and analysed initial data sets and helped train members of my group</gtr:partnerContribution><gtr:piContribution>We have produced large quantities of pure complexes of the protein kinase TOR in a complex with LST8</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Chiron Corp</gtr:department><gtr:description>Establishment of a structure-based PI3K drug discovery programme at Chiron</gtr:description><gtr:id>E0FEB171-A692-4CC2-A08E-4A49A191EF27</gtr:id><gtr:impact>Chron established a PI3K structure programme for developing their inhibitors.</gtr:impact><gtr:outcomeId>43EF6FAA127-1</gtr:outcomeId><gtr:piContribution>We provided protocols for expression, purification and crystallisatiobn of PI3K gamma. We provided plasmids and viruses to facilitate expression.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Guy's Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Structure and function of MITD1</gtr:description><gtr:id>5F13F1FE-9269-4CF7-BDB6-5285258D8647</gtr:id><gtr:impact>Two publications, PUBMED ID 23045692 and 
 22405001</gtr:impact><gtr:outcomeId>56dc1ad9307770.62904709-1</gtr:outcomeId><gtr:partnerContribution>Monica has determined the role of MITD1 in cells</gtr:partnerContribution><gtr:piContribution>We have determined structures of MITD1 and associated proteins</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Colorado Boulder</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Chemistry and Biochemistry</gtr:department><gtr:description>Studies of phosphoinositide signalling using single molecule fluorescence methods on supported bilayers</gtr:description><gtr:id>2D665931-EBC3-409C-BB82-2ABF2CB9912A</gtr:id><gtr:impact>Two publications: 
PMID: 27933776 
PMID: 27119641</gtr:impact><gtr:outcomeId>58c135048306c4.40711087-1</gtr:outcomeId><gtr:partnerContribution>Falke and his clleagues have used our material to characterise the molecular mechanisms whereby the activity of the enzymes is regulate on membranes</gtr:partnerContribution><gtr:piContribution>We have provided samples of various purified enzymes for studies of activity and difussion on membranes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Basel</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Structural and functional studies of PI3Ks</gtr:description><gtr:id>6F9C9258-6CDD-4E03-8848-A5964C122347</gtr:id><gtr:impact>publication 23824069</gtr:impact><gtr:outcomeId>56dc4e966bc548.38052490-1</gtr:outcomeId><gtr:partnerContribution>Matthis Wymann has determine the activity of PI3K gamma complexes in cells</gtr:partnerContribution><gtr:piContribution>We have carried out HDX-MS studies of p110gamma/p84 complexes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Virginia (UVa)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Health Sciences Centre</gtr:department><gtr:description>Structures of helical assemblies by electron microscopy</gtr:description><gtr:id>73491B88-47D4-46A7-BFCF-2D54D5527395</gtr:id><gtr:impact>Publication 18786397</gtr:impact><gtr:outcomeId>6E2A184CDBC-1</gtr:outcomeId><gtr:partnerContribution>Prof. Egelman provided expertise necessary to determine the structures of helical assemblies of ESCRT complexes</gtr:partnerContribution><gtr:piContribution>We deterines the structure of ESCRT-III filaments by electron microscopy with the help of Prof. Egelman</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Intellikine, Inc.</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Modelling flexibility in PI3Ks</gtr:description><gtr:id>3C87F3A3-4EDD-46F2-9CF7-634302606F30</gtr:id><gtr:impact>We have published our structures and conclusions in Nature Chemical Biology. This is in press and due to be published in February, 2010.</gtr:impact><gtr:outcomeId>0552305C5C2-1</gtr:outcomeId><gtr:partnerContribution>We have had ongoing discussions related to designing new PI3K inhibitors</gtr:partnerContribution><gtr:piContribution>We determined structures of complexes of isotype-specific inhibitors of PI3K delta with specific inhbitors developed by Intellikine. We also developed computational tools to model the flexibility of PI3Ks.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Structures of spindle-pole body complexes</gtr:description><gtr:id>DEC2AE1C-2D22-4E32-9992-AE7D91031B5C</gtr:id><gtr:impact>We have published the structure and the invivo assembly of components of the spindle-pole body pubmed id: 16785321</gtr:impact><gtr:outcomeId>CFA71735B92-1</gtr:outcomeId><gtr:partnerContribution>They have provided crystals of purified protein complexes</gtr:partnerContribution><gtr:piContribution>We have helped determine protein structures of complexes involved in spindle-pole bodies</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Research and Development AstraZeneca</gtr:department><gtr:description>Cryo-EM structures and functional studies of full length ATM &amp;amp; ATR: A molecular understanding of the regulation of DNA damage repair</gtr:description><gtr:id>5D44BEB3-2737-46BC-B48C-B43C17E8AF0D</gtr:id><gtr:impact>There have been no reportable outcomes yet</gtr:impact><gtr:outcomeId>56dc0d40011094.29971882-1</gtr:outcomeId><gtr:partnerContribution>Through the AZ/LMB Blue Skies Innitiative, we have received funding for one postdoctoral researcher. AZ has also provided us large-scale cell cultures expressing the enzymes.</gtr:partnerContribution><gtr:piContribution>We are determining structures of the PI3K-related protein kinases ATM and ATR.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Chemistry of PI3K inhibiors</gtr:description><gtr:id>44605756-78A5-478F-A86A-67343491884B</gtr:id><gtr:impact>These collaborations have resulted in sev eral publications including: 16647110 18849971</gtr:impact><gtr:outcomeId>7BA96C191EA-1</gtr:outcomeId><gtr:partnerContribution>Colleages in Kevan Shokat's group have provided a wide range of compounds that are inhibitors of PI3Ks. These have been central to our ongoing structural studies of these enzymes.</gtr:partnerContribution><gtr:piContribution>We determined the structures od a range of complexes of PI3Ks with isotype-selective inhibitors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Signalling</gtr:department><gtr:description>Regulation of autophagy induction by the VPS34 complexes: structural and functional studies</gtr:description><gtr:id>309D4519-7189-40A4-A1AB-27A06050A58F</gtr:id><gtr:impact>One publication, PUBMED ID 26450213</gtr:impact><gtr:outcomeId>56dc32217128c9.15540058-1</gtr:outcomeId><gtr:partnerContribution>Nicholas has assayed autophagy in mammalian cells</gtr:partnerContribution><gtr:piContribution>We have determined structures, in vitro activities, dynamics and membrane binding for several Vps34-containing complexes</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cornell University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Protein trafficking to lysosomes via ESCRT complexes</gtr:description><gtr:id>DD7680D9-52C2-4965-9AFD-767D460B79F3</gtr:id><gtr:impact>Our structures have been the basis for several publications 16615893 17215868 17450176</gtr:impact><gtr:outcomeId>22CD19C2D04-1</gtr:outcomeId><gtr:partnerContribution>We have published a series of papers with our structures and cellular sorting results from Scot Emr's groupDr. Urbe has been helped us decide important research directions that understanding lysosomal trafficking</gtr:partnerContribution><gtr:piContribution>We have determined three-dimensional structures of a range of endosomal complexes involved in sorting membrane proteins into multivesicular bodies for degradation in lsosomes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>structure and function of p110 beta/ p85 beta</gtr:description><gtr:id>C1C9A3D4-E79E-4FA6-86F2-7159BF13C66F</gtr:id><gtr:impact>publication 21362552</gtr:impact><gtr:outcomeId>QsGxa92yJTR-1</gtr:outcomeId><gtr:partnerContribution>They have been involved in various aspects of our reserch programme, including mass spectrometry for assaying PI3Ks and mouse studies of structure guided mutations</gtr:partnerContribution><gtr:piContribution>We have determined structures of the complexes of p110 beta with regulatory subunits</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanofi</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Aventis</gtr:department><gtr:description>Establishment of a structure-based PI3K drug discovery programme at Sanofi-Aventis</gtr:description><gtr:id>3CA4662F-46D6-4B93-B421-CF8DD227D656</gtr:id><gtr:impact>Sanofi-Aventis established a PI3K structure programme for developing their inhibitors.</gtr:impact><gtr:outcomeId>D8E9114112E-1</gtr:outcomeId><gtr:piContribution>We provided protocols for expression, purification and crystallisatiobn of PI3K gamma. We provided plasmids and viruses to facilitate expression.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>PI3K delta activity in pathogenesis of APDS</gtr:description><gtr:id>F42E60A2-EDB4-4DC8-9D3C-69E4520D09A8</gtr:id><gtr:impact>One publication, pubmed id 
 24136356</gtr:impact><gtr:outcomeId>56dc1f4d2e8a26.75339317-1</gtr:outcomeId><gtr:partnerContribution>Alison has characterised the cells of APDS patients</gtr:partnerContribution><gtr:piContribution>We have characterised the activity and membrane interqactions of mutants of p110 delta associated with familial immune disorders</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Protein trafficking to lysosomes via ESCRT complexes</gtr:description><gtr:id>B14AF2F5-DA62-42C1-879B-2314B57991D3</gtr:id><gtr:impact>Our structures have been the basis for several publications 16615893 17215868 17450176</gtr:impact><gtr:outcomeId>22CD19C2D04-2</gtr:outcomeId><gtr:partnerContribution>We have published a series of papers with our structures and cellular sorting results from Scot Emr's groupDr. Urbe has been helped us decide important research directions that understanding lysosomal trafficking</gtr:partnerContribution><gtr:piContribution>We have determined three-dimensional structures of a range of endosomal complexes involved in sorting membrane proteins into multivesicular bodies for degradation in lsosomes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Signalling</gtr:department><gtr:description>Regulation of autophagy induction by the Vps34 complex: structural and functional studies</gtr:description><gtr:id>4B49814E-2F44-47F3-A0C2-85FF62E1C1D1</gtr:id><gtr:impact>Several structures have been determined and publictions are in progress</gtr:impact><gtr:outcomeId>54649a0733ef24.31476971-1</gtr:outcomeId><gtr:partnerContribution>Our work is primarily structural. The structures we are determining are being used as a framework for designing functional studies of these complexes by researchers in the Babraham Institute.</gtr:partnerContribution><gtr:piContribution>We are collaborating on the structures of Vps34-containing complexes</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Vertex Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Establishment of a PI3K structure-based drug develpment programme</gtr:description><gtr:id>3A6ADEB3-DDB0-402F-B05D-E862A7A8822E</gtr:id><gtr:impact>Vertex established a structural component of their drug discovery programme for PI3K</gtr:impact><gtr:outcomeId>2A1DD3D52EC-1</gtr:outcomeId><gtr:piContribution>We provided expression, purification and crystallisation protocols for PI3K gamma. We also provided plasmids and viruses for insect cell expression.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Warner-Lambert</gtr:department><gtr:description>Crystal structure of PI3K gamma</gtr:description><gtr:id>F265FEBB-66CA-4AC5-B989-1E65E7C74B9F</gtr:id><gtr:impact>Protocols established in this collaboration resulted in a series of publications including pubmed ids: 10580505 11090628 11136978 16647110 18849971</gtr:impact><gtr:outcomeId>F0E72B8870E-1</gtr:outcomeId><gtr:partnerContribution>We collaborated in developing approches to designing PI3K inhibitors</gtr:partnerContribution><gtr:piContribution>We determined the first structure of a phosphoinositide 3-kinase.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Illinois</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Phosphoinositide recognition moduels</gtr:description><gtr:id>6D7A7F54-2955-4716-864E-296466492693</gtr:id><gtr:impact>Publications: 17038310 17581820 1764168</gtr:impact><gtr:outcomeId>A253576C8A7-1</gtr:outcomeId><gtr:partnerContribution>Prof. Cho has characterised the physics of interactions of recognition modules for lipid membranes. This has helped us understand our structures of these modules.</gtr:partnerContribution><gtr:piContribution>We have determined the structures of phosphoinositide-recognition modules such as PX domains</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mount Sinai Hospital (Canada)</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Samuel Lunenfeld Research Institute</gtr:department><gtr:description>The role of PTEN in Wnt signalling</gtr:description><gtr:id>37A28207-8051-4747-9E50-0A5492280E53</gtr:id><gtr:impact>One publication, 26399523</gtr:impact><gtr:outcomeId>56dc4d4d7036e3.64495665-1</gtr:outcomeId><gtr:partnerContribution>They characterised the role of PTEN in cilia formation</gtr:partnerContribution><gtr:piContribution>We assayed in vitro activities of PTEN mutants</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Developing activators of lipid kinases</gtr:description><gtr:id>2969A648-C21D-4D3A-B60D-516F74E5E224</gtr:id><gtr:impact>The collaboration has so far discovered a set of putative activators.</gtr:impact><gtr:outcomeId>58c15558e5d0a2.92741069-1</gtr:outcomeId><gtr:partnerContribution>AstraZeneca carried out a large-scale screen of a compound library using our assays. Our collaborators at UCL will be involved in using these inhibitors in various biological contexts.</gtr:partnerContribution><gtr:piContribution>We developed an assay to select for small molecules that would activate lipid kinases. We also will investigate the mechanism of activation using HDX-MS.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Texas A&amp;M University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HDX-MS studies of lipid transfer proteins</gtr:description><gtr:id>AD04CE90-7FE9-4291-A670-9EBCE6BAA305</gtr:id><gtr:impact>No reportable output yet</gtr:impact><gtr:outcomeId>56dc1d2e249d64.98558270-1</gtr:outcomeId><gtr:partnerContribution>They have provided purified proteins</gtr:partnerContribution><gtr:piContribution>We have analysed PI transfer proteins using HDX-MS to determine how they interact with lipids and membranes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Albert Einstein College of Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Mechanisms of PI3K-driven oncogenesis</gtr:description><gtr:id>28AFCE2C-7CDE-4D30-AF41-E2AA5C67CCF4</gtr:id><gtr:impact>Four publications, PUBMED IDs, 17626883, 23211529, 23328076, 24190998</gtr:impact><gtr:outcomeId>56dc1bff3ed215.42804914-1</gtr:outcomeId><gtr:partnerContribution>Jonathan has examind the impact of input-ablated mutants on oncogenesis in vitro</gtr:partnerContribution><gtr:piContribution>We have analysed regulation of PI3K complexes using HDX-MS</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Colorado Boulder</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Chemistry and Biochemistry</gtr:department><gtr:description>Single-molecule imaging of PI3K and PTEN activity on membranes</gtr:description><gtr:id>8027B5C1-DAB3-47F1-ADE0-F8C29DB3B03C</gtr:id><gtr:impact>Two publications</gtr:impact><gtr:outcomeId>56dc20457caaa0.21124588-1</gtr:outcomeId><gtr:partnerContribution>Joseph has characterised the activity, diffusion and lipid interactions using single-molecule spectrometry</gtr:partnerContribution><gtr:piContribution>We have provided large quantities of purified PI3K and PTEN</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>The molecular basis of PI3Kgamma in autoimmune lymphoproliferative syndrome</gtr:description><gtr:id>128D521E-559E-49F7-A06D-B8D20D9663B9</gtr:id><gtr:impact>No reportable output yet</gtr:impact><gtr:outcomeId>56dc36e3a9ee09.44524159-1</gtr:outcomeId><gtr:partnerContribution>Our partners have assayed the inluence of the p110gamma mutations in human cells</gtr:partnerContribution><gtr:piContribution>We have assayed the PI3K activity of p110gamma mutants associated with familial autoimmune disease</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>FindAPhD Fair - Cambridge</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BE93A2AE-6DEB-4116-B7E3-AABCC321814D</gtr:id><gtr:impact>Ksenia Rostislavleva, a Ph.D. student in the group, helped assemble a set of posters and a stand to advise undergratuates about careeres in research at the Laboratory of Molecular Biology</gtr:impact><gtr:outcomeId>56bdedaa1a91c9.17118840</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Structural biology as a tool for finding new pharmaceutical agents</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2469A86D-9D36-4179-A09D-E78ADB6AE7B3</gtr:id><gtr:impact>The group of sixth form students who visited the institute learned about the mission of the LMB and some basic principles of strutural biology as applied to drug discovery. In addition, they took part in a discussion with several scientists on various aspects of a career as a scintist and practical information for applying to University,

After the talk in 2013, the sixth form requested that we repeat this is 2014.</gtr:impact><gtr:outcomeId>5464974a0c66a5.91973411</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Long Road 6th form</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BF8523A4-0154-4E22-A70A-4AA6204491F2</gtr:id><gtr:impact>About 10 sixth form students toured the lab, and we answered questions about research and medical careers</gtr:impact><gtr:outcomeId>56bde933ccccd9.58443307</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Ridgefield Primary School Science Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C139C684-0D69-47B1-A48E-1F947FD6D898</gtr:id><gtr:impact>Presentation for school children by Glenn Masson</gtr:impact><gtr:outcomeId>56dc5b417fd883.55499826</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Home in the Service of Science</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>27E102FF-2AE2-42B8-B4EF-9C9CDB604345</gtr:id><gtr:impact>&amp;quot;Home in the Service of Science&amp;quot; is an art installation in the LMB. Olga Perisic in the group participated in a public event to open the installation for the general public.</gtr:impact><gtr:outcomeId>58c15916c69825.11321486</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>long road 6th form</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>947296CD-CC01-4C97-9D00-2411D98C027D</gtr:id><gtr:impact>We hosted the visit of 10 top 6th form students to talk about careers in molecular biology with an emphasis on molecular medicine.

The head of studies at the sixth form reported that students found the visit helpful and that they were interested in establishing a work experience program.</gtr:impact><gtr:outcomeId>ZBjnCrkMckJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biochemical Society  Big Biology Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>0657D708-68E3-455B-BB69-3E7E0F3BF122</gtr:id><gtr:impact>Two members of the group participated in a &amp;quot;Medicine Makers&amp;quot; event developed by the Biochemical Society and British Pharmacological Society. This was held in Cambridge at the at &amp;quot;Big Biology Day&amp;quot;.</gtr:impact><gtr:outcomeId>58c13cc3a9c049.33439057</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society annual exhibition</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8B604164-BE23-4996-BF06-E0B645DFECD5</gtr:id><gtr:impact>Olga Perisic spent a day as a volunteer talking to visitors at a stand at the Royal Society annual exhibition called &amp;quot;Virus wars - antibodies strike back&amp;quot; which celebrated our immune system, research and 100 years of the MRC , Saturday 6th July 2013.</gtr:impact><gtr:outcomeId>56bdf9e3e51518.42087085</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Festival, Cambridge</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EBCF5029-88AD-41B4-9501-E837B5CBD36B</gtr:id><gtr:impact>Glenn Masson helped man am LMB booth at the Science Festival</gtr:impact><gtr:outcomeId>56dc5bc6c6a090.13407429</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cambridge Cancer Centre Studentship (Rotislavleva)</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK Cambridge Institute</gtr:fundingOrg><gtr:id>C4890F32-680F-4AAD-9944-E10DB180DDE8</gtr:id><gtr:outcomeId>gkAEUGVHj3b</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>281240</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Merck Serono</gtr:department><gtr:description>Research Grant Serono</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>Merck</gtr:fundingOrg><gtr:fundingRef>LSF 24463-blsf8555</gtr:fundingRef><gtr:id>41CB0A79-C2F3-4CA9-90B5-0ACA053A5F8C</gtr:id><gtr:outcomeId>hcq8sz9GFvc</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2005-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Long Term Fellowship (Burke)</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>18AE4191-238D-4FC8-9656-37C8F4A5B9C2</gtr:id><gtr:outcomeId>D44BD1F256F0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Long Term Fellowship (Sachse)</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>789A4AF3-A7D9-4DE6-8C60-61F48B309AD1</gtr:id><gtr:outcomeId>iFQjNs5SgQV0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>38000</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SNSF Postdoctoral Fellowship (Vadas)</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Swiss National Science Foundation</gtr:fundingOrg><gtr:id>FF730F8A-0119-43E1-BF2E-CB499F656A88</gtr:id><gtr:outcomeId>F8E8EF558390</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>95000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>LMB Cambridge Scholarship (Baretic) The Cambridge Trust</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>01705E5D-FC61-4BB3-9CB3-41B6195AB216</gtr:id><gtr:outcomeId>hNvbX28ENxX0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>95000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>LMB Cambridge Scholarship (Zhang) The Cambridge Trust</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D2438CC7-6036-4372-A3D3-F6099DC3D649</gtr:id><gtr:outcomeId>gu66QFc5a4z0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>124296</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie Intra European Fellowship (Vadas)</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>02D71957-B424-4F38-AB31-4B087ED8F8A7</gtr:id><gtr:outcomeId>ZN4kY5yY3Wm0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>561453</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Programme Grant (Assembly and disassembly ESCRTs on membranes)</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>FD537DCF-D9A4-4EC9-B7D1-BAAD9166E6C7</gtr:id><gtr:outcomeId>86B57D011BD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Intellikine Inc</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Intellikine, Inc.</gtr:fundingOrg><gtr:id>1020DBD1-38AB-4FDA-A060-234A9A091572</gtr:id><gtr:outcomeId>56d866b11c8aa1.94866397</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>29010</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>FEBS long-term fellowship (Anandapadamanaban)</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Federation of European Biochemical Societies (FEBS)</gtr:fundingOrg><gtr:id>8459D20B-C2DA-4734-A4E8-2CEF1BC377A4</gtr:id><gtr:outcomeId>58b59217a71502.95559395</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7500</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Long Term Fellowship (Vadas)</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>D66B5725-6A85-4538-81F2-BBAF402CC456</gtr:id><gtr:outcomeId>609CCCFF38C0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AstraZeneca/LMB Blue-Skies Inniative. Structures of ATM and ATR complexes</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>97A5F1E5-6366-42C9-BC79-CDF8D3E2E519</gtr:id><gtr:outcomeId>56dc581cea1453.86963182</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>384252</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cancer Research UK Science Committee - Programme Award</gtr:description><gtr:end>2021-02-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C14801/A21211</gtr:fundingRef><gtr:id>D720EA99-7C02-4794-8E7B-CF36887C7A8E</gtr:id><gtr:outcomeId>56bde829684e95.33277764</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Research Grant Intellikine</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Intellikine, Inc.</gtr:fundingOrg><gtr:id>860D4912-734B-4A49-BE3F-30597E1AB0CB</gtr:id><gtr:outcomeId>HRtVPd9FTsK</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>St Catharine's College</gtr:department><gtr:description>St Catharines College JRF (Masson)</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>E5DFA0E3-39CC-4A45-9543-568CA1927042</gtr:id><gtr:outcomeId>56d874e6d95210.61189865</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>38000</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SNSF Fellowship (Vadas)</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Swiss National Science Foundation</gtr:fundingOrg><gtr:id>F57AFEC6-119E-4802-9FAF-F0FE9539955D</gtr:id><gtr:outcomeId>Yi4tqeugT2x0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120465</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC 2012 Responsive Mode Grant</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/K019155/1</gtr:fundingRef><gtr:id>33AAE045-0333-4E8F-89E1-B6A00E8EEA07</gtr:id><gtr:outcomeId>jyGSWsneixd</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AstraZeneca-LMB Collaboration</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:id>31935121-7C72-47A8-BF91-EA17DE6D18CE</gtr:id><gtr:outcomeId>56d8653ea53cd6.62048653</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Long Term Fellowship (Pobbati)</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>3820E39D-B276-4B7F-9D36-A1B757E7E8D9</gtr:id><gtr:outcomeId>qdMqALJraVR0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the MRC Molecular and Cellular Medicine Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2DBBAD98-F13B-4B73-A369-D259B26B79A6</gtr:id><gtr:outcomeId>58c13dc2cc2374.49111904</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chairman Scientific Advisory Board, PIQUR Therapeutics</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>8D5BB8E5-E250-4315-8571-60C9F4BE8538</gtr:id><gtr:outcomeId>56dc5e06d3fab9.59610997</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Scientific advisory board for max planck society, dortmund</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>FD24BAB6-FA5E-45BF-A3D4-7E9873A41006</gtr:id><gtr:outcomeId>NMYRVVXnGJ9</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Diamond Light source peer review panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>683B166C-F846-4FB6-94B0-8EB21E508C0E</gtr:id><gtr:outcomeId>dCSncwZGwvr</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed a bacterial poly-cistronic expression system that we use to simultaneously express up to eight proteins. The system is used to express multi-subunit complexes with a variety of tags to facilitate X-ray crystallography, fluorescence spectroscopy and other biophysical techniques. The system involves a set of &amp;quot;shuttle&amp;quot; vectors as well as co-expression vectors. It has been been the basis for many of the structures that we have determined in the last five years, including the ESCRT complexes and catalytic/regulatory complexes for the PI 3-kinases. Work using these vectors has been published and the vectors have been provided to many researchers in the LMB and elsewhere.</gtr:description><gtr:id>6841317A-6D4B-4D62-8E22-387032C6AEAF</gtr:id><gtr:impact>Without these vectors, many complexes would have been impossible to obtain. It is common that components of biological complexes cannot be obtained in isolation. These vectors have enabled us to go from no measurable expression for isolated components to massive yields of complexes suitable for X-ray crystallography.</gtr:impact><gtr:outcomeId>0785491332A</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>co-expresson vectors for protein complexes</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We developed a baculovirus expression system that has enabled us to express lare quantities of class IA phhosphoinositide 3-kinases. The system has enabled us to express all of the mammalian PI 3-kinases in a manner that is amenable to determining high-resolution structures of the complexes of the enzyme with isotype-specific inhibitors. The system is particularly well suited to inhibitors of p110delta, p110alpha and p110beta. The details of this system have only ben disclosed at this time to our industrial collaborators at Merck-Serono. We expect to make full public disclosure by the end of 2008.</gtr:description><gtr:id>00BB9E47-3D85-4780-AE5D-E2ABFD83815A</gtr:id><gtr:impact>This has allowed us to obtain the first structures of type IA PI 30kinases that are suitable for drug discovery programmes.</gtr:impact><gtr:outcomeId>CE6B30E9362</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>baculovirus expression system for IA PI3Ks</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed detailed protocols for producing crystals of phosphoinositide 3-kinase gamma that can be used to determine the structures of complexes of the enzyme with small-molecule inhibitors. These include for expression in bacullovirus, purification, crystallisation, soaking crystals with compounds and crystal freezing protocols. We have communicated these protocols to various companies who have received materials from us. Without these protocols, it is difficult to produce high resolution structures.</gtr:description><gtr:id>6356A582-7E57-4240-A8E7-E85CE5998DD5</gtr:id><gtr:impact>The protocols and the reagents that we have provided (viruses, purified protein and bacmids). Have facilitated many drug discovery programmes aimed at specific PI 3-kinase inhibitors.</gtr:impact><gtr:outcomeId>28AA05BD698</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PI3K crystallisation protocols</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>763554DF-6E05-42FC-8486-AE08E2BFC12D</gtr:id><gtr:title>Phosphoinositide-specific phospholipase C delta1 activity toward micellar substrates, inositol 1,2-cyclic phosphate, and other water-soluble substrates: a sequential mechanism and allosteric activation.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1ae91a136cc1808e002adb45e242f69"><gtr:id>e1ae91a136cc1808e002adb45e242f69</gtr:id><gtr:otherNames>Wu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1997-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>pm_12679_979_9287165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF16CC48-7DF2-4024-917C-A80F06315352</gtr:id><gtr:title>PIKKs--the solenoid nest where partners and kinases meet.</gtr:title><gtr:parentPublicationTitle>Current opinion in structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81ea4b7d79bc30e35cf90eb0329fe41b"><gtr:id>81ea4b7d79bc30e35cf90eb0329fe41b</gtr:id><gtr:otherNames>Baretic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-440X</gtr:issn><gtr:outcomeId>5675dd57b3010</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B5E4B86-FB0A-4DEF-99C6-B936A66F2846</gtr:id><gtr:title>Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6bc297ca1464666551c0194d7923e51"><gtr:id>b6bc297ca1464666551c0194d7923e51</gtr:id><gtr:otherNames>Miled N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>7357E292557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFC735DD-1C7B-40F9-AA25-C9D7494AA426</gtr:id><gtr:title>Regulation of PI3K by PKC and MARCKS: Single-Molecule Analysis of a Reconstituted Signaling Pathway.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/699981ce0981bf01f018b788882918b1"><gtr:id>699981ce0981bf01f018b788882918b1</gtr:id><gtr:otherNames>Ziemba BP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>58b589e4cf5094.61706782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CCA1769-3C32-4B0F-B19F-81806020ED43</gtr:id><gtr:title>Nanoscale flexibility parameters of Alzheimer amyloid fibrils determined by electron cryo-microscopy.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d811dc4cc611410b04837e4a1a4d913"><gtr:id>7d811dc4cc611410b04837e4a1a4d913</gtr:id><gtr:otherNames>Sachse C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>QJxG4iq6QhR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6FB14ED-0933-4B46-9F2D-DF2549CD4687</gtr:id><gtr:title>A segment of cold shock protein directs the folding of a combinatorial protein.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e33fae4a9419ff1a059adededca2b206"><gtr:id>e33fae4a9419ff1a059adededca2b206</gtr:id><gtr:otherNames>de Bono S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12679_19_15671167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE1814D9-B8CB-4CA4-9B3C-A5FE902A71EF</gtr:id><gtr:title>PB1 domain-mediated heterodimerization in NADPH oxidase and signaling complexes of atypical protein kinase C with Par6 and p62.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f71e1cd64d74a8f18ba7620e36319531"><gtr:id>f71e1cd64d74a8f18ba7620e36319531</gtr:id><gtr:otherNames>Wilson MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_12679_19_12887891</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5BC5142-ECBB-441A-B0B8-117F719CB9E0</gtr:id><gtr:title>Structure and disassembly of filaments formed by the ESCRT-III subunit Vps24.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fac3124c7ba883bdfa239e77d45f6262"><gtr:id>fac3124c7ba883bdfa239e77d45f6262</gtr:id><gtr:otherNames>Ghazi-Tabatabai S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>62241F2295C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35AC12C1-C976-468C-B9D2-DE32C4AFB490</gtr:id><gtr:title>The structure of a tunicate C-type lectin from Polyandrocarpa misakiensis complexed with D -galactose.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0757d1f73b9e3b41f60a3665b9f5342c"><gtr:id>0757d1f73b9e3b41f60a3665b9f5342c</gtr:id><gtr:otherNames>Poget SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pm_12679_19_10398588</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>322EFF83-900A-43E5-B039-66C667EE0027</gtr:id><gtr:title>The 1.9 A crystal structure of a nucleoside diphosphate kinase complex with adenosine 3',5'-cyclic monophosphate: evidence for competitive inhibition.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d89828b359acca2f29f3088c1ea0602c"><gtr:id>d89828b359acca2f29f3088c1ea0602c</gtr:id><gtr:otherNames>Strelkov SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1995-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pm_12679_779_7783219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A3CD4C4-D44C-47AE-B978-5D814028A051</gtr:id><gtr:title>Regulation of a Coupled MARCKS-PI3K Lipid Kinase Circuit by Calmodulin: Single-Molecule Analysis of a Membrane-Bound Signaling Module.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/699981ce0981bf01f018b788882918b1"><gtr:id>699981ce0981bf01f018b788882918b1</gtr:id><gtr:otherNames>Ziemba BP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>58c13049f15443.12115094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8C475D0-C55B-429C-88BF-19045375F4A7</gtr:id><gtr:title>Structural mapping of the catalytic mechanism for a mammalian phosphoinositide-specific phospholipase C.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e4907cc520007b00ff1255ae9415d22"><gtr:id>7e4907cc520007b00ff1255ae9415d22</gtr:id><gtr:otherNames>Essen LO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1997-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>pm_12679_979_9048554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06CC2A5A-C1C2-42C5-A127-8AFC05344031</gtr:id><gtr:title>Phosphoinositide-specific phospholipase C: structural basis for catalysis and regulatory interactions.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60a70505a2dffe17388dc34b80e2e4ec"><gtr:id>60a70505a2dffe17388dc34b80e2e4ec</gtr:id><gtr:otherNames>Katan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1997-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn><gtr:outcomeId>pm_12679_19_10024492</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEEB604E-899B-4882-BAD1-DE12315AD053</gtr:id><gtr:title>Dynamics of the phosphoinositide 3-kinase p110d interaction with p85a and membranes reveals aspects of regulation distinct from p110a.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c65b62a487af132fc0d937764453fbe"><gtr:id>3c65b62a487af132fc0d937764453fbe</gtr:id><gtr:otherNames>Burke JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>MeiDai3wiiD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C751693-EE87-4225-BE3C-63AA7D4B2CE3</gtr:id><gtr:title>Binding of the PX domain of p47(phox) to phosphatidylinositol 3,4-bisphosphate and phosphatidic acid is masked by an intramolecular interaction.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8db7790cff00d55a393fd93b4e05e0eb"><gtr:id>8db7790cff00d55a393fd93b4e05e0eb</gtr:id><gtr:otherNames>Karathanassis D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_12679_19_12356722</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2AE2CF4-CB8B-41FF-AEC1-48263DFAFFF6</gtr:id><gtr:title>Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody.</gtr:title><gtr:parentPublicationTitle>Protein engineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d8dc57afcc02600707257783872e92c"><gtr:id>1d8dc57afcc02600707257783872e92c</gtr:id><gtr:otherNames>Holliger P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1996-01-01</gtr:date><gtr:issn>0269-2139</gtr:issn><gtr:outcomeId>pm_12679_879_8736497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3245F5AE-225F-4DB3-93F6-EA4A73A6744D</gtr:id><gtr:title>Structural basis for selective recognition of ESCRT-III by the AAA ATPase Vps4.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45d02b56369c9790f9eb7eec81683613"><gtr:id>45d02b56369c9790f9eb7eec81683613</gtr:id><gtr:otherNames>Obita T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>A1C28668503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E17F5C4-BD33-473A-972F-3EE2BBFC2D69</gtr:id><gtr:title>Structural studies of phosphoinositide 3-kinase-dependent traffic to multivesicular bodies.</gtr:title><gtr:parentPublicationTitle>Biochemical Society symposium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07f1b1792355345b4d69d0eda4b425a1"><gtr:id>07f1b1792355345b4d69d0eda4b425a1</gtr:id><gtr:otherNames>Gill DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0067-8694</gtr:issn><gtr:outcomeId>E86F01CE1AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98DE592E-F682-43DC-A2E1-BBD4248EBAB3</gtr:id><gtr:title>The function of phosphatidylinositol 5-phosphate 4-kinase ? (PI5P4K?) explored using a specific inhibitor that targets the PI5P-binding site.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc0a6cb49e72c1bb5ba022e76dbab30b"><gtr:id>cc0a6cb49e72c1bb5ba022e76dbab30b</gtr:id><gtr:otherNames>Clarke JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>56a92ff914bb77.16566005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C1DB2BA-8BE2-4C71-8E6F-970263473342</gtr:id><gtr:title>The 2.0-A resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fdf2e003098d4789eabc103615acaba"><gtr:id>5fdf2e003098d4789eabc103615acaba</gtr:id><gtr:otherNames>Pei XY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1997-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12679_979_9275175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83725578-8B09-4D8C-93B7-B9CF7F3171DF</gtr:id><gtr:title>Synergy in activating class I PI3Ks.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c65b62a487af132fc0d937764453fbe"><gtr:id>3c65b62a487af132fc0d937764453fbe</gtr:id><gtr:otherNames>Burke JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>56a92fd4c10ec6.43642783</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA92E5AA-0184-4278-8E11-B2B5492E5FE1</gtr:id><gtr:title>Deconvolution of Buparlisib's mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5d1afa0e1247753d7329fcf4184f477"><gtr:id>b5d1afa0e1247753d7329fcf4184f477</gtr:id><gtr:otherNames>Bohnacker T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58c6d5086646a6.24521619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B5AEC88-E7EA-4EF0-B921-7A20CA3ED082</gtr:id><gtr:title>Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/080d78db4f4d727f5aee526b40b7d80f"><gtr:id>080d78db4f4d727f5aee526b40b7d80f</gtr:id><gtr:otherNames>D'Angelo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_12679_29_23913272</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>490E1696-D156-4197-919E-E849AC42B105</gtr:id><gtr:title>Mapping the phospholipid-binding surface and translocation determinants of the C2 domain from cytosolic phospholipase A2.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3492eb3c66c7abc5082d626ef7a92d73"><gtr:id>3492eb3c66c7abc5082d626ef7a92d73</gtr:id><gtr:otherNames>Perisic O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12679_19_10329700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4195B8A8-80BF-4F1C-A430-181A643BD444</gtr:id><gtr:title>Allosteric activation of PI3Ka by oncogenic mutations.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c65b62a487af132fc0d937764453fbe"><gtr:id>3c65b62a487af132fc0d937764453fbe</gtr:id><gtr:otherNames>Burke JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>pm_12679_29_23563630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C0D4B50-0419-4BE0-9951-8BE9C1404807</gtr:id><gtr:title>Molecular and structural basis of ESCRT-III recruitment to membranes during archaeal cell division.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c757ef1f77eb83d0ae49eca1ee8d6c9"><gtr:id>0c757ef1f77eb83d0ae49eca1ee8d6c9</gtr:id><gtr:otherNames>Samson RY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>tMythULoNWX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>343EA031-8FA8-4CD0-820A-C7C9DA096BAA</gtr:id><gtr:title>ESCRT-III binding protein MITD1 is involved in cytokinesis and has an unanticipated PLD fold that binds membranes.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ef589004c3149e1d085d244be7eb3d9"><gtr:id>3ef589004c3149e1d085d244be7eb3d9</gtr:id><gtr:otherNames>Hadders MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12679_29_23045692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E90170A1-444F-4F3A-8303-BA64152D75A3</gtr:id><gtr:title>Structural views of phosphoinositide-specific phospholipase C: signalling the way ahead.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/503bcc65a41fb82d61a7edfd9655d88a"><gtr:id>503bcc65a41fb82d61a7edfd9655d88a</gtr:id><gtr:otherNames>Williams RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1996-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_12679_879_8994965</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2A89DE7-8D34-42A3-A0DB-F0D962A32CF8</gtr:id><gtr:title>Catalytic domain of phosphoinositide-specific phospholipase C (PLC). Mutational analysis of residues within the active site and hydrophobic ridge of plcdelta1.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2081763553d931c257bb09989671ccaf"><gtr:id>2081763553d931c257bb09989671ccaf</gtr:id><gtr:otherNames>Ellis MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1998-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12679_979_9565585</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC918ADF-43DF-4D64-8DB6-96F686F2F4ED</gtr:id><gtr:title>Three-dimensional structure of TspO by electron cryomicroscopy of helical crystals.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/524281bdef0ba75cf4cfe26e07670890"><gtr:id>524281bdef0ba75cf4cfe26e07670890</gtr:id><gtr:otherNames>Korkhov VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>iUngLbMWSWZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5889AB5D-00DB-4AE3-A975-3C55C48A1B44</gtr:id><gtr:title>Structural role of Sfi1p-centrin filaments in budding yeast spindle pole body duplication.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8a46f3752fd4026773cf1b531707cbf"><gtr:id>b8a46f3752fd4026773cf1b531707cbf</gtr:id><gtr:otherNames>Li S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>AA2BA947B76</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87F4D523-F8BE-4CF6-9D69-7FD1B2F153CB</gtr:id><gtr:title>Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/773f51694c81fa0805c69c6e23f77df1"><gtr:id>773f51694c81fa0805c69c6e23f77df1</gtr:id><gtr:otherNames>Miller S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>545ce2b48649c0.80133920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79E7FBE2-7AD8-444B-8D49-130E36D774A3</gtr:id><gtr:title>Structural and mechanistic comparison of prokaryotic and eukaryotic phosphoinositide-specific phospholipases C.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/daa42dc7dd19f22186351d4274638b49"><gtr:id>daa42dc7dd19f22186351d4274638b49</gtr:id><gtr:otherNames>Heinz DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1998-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pm_12679_979_9466937</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D5E4461-2454-4E40-9C8C-2C6B792D7445</gtr:id><gtr:title>ESCRT-II, an endosome-associated complex required for protein sorting: crystal structure and interactions with ESCRT-III and membranes.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19638366913ccf65a0e6143096ef886e"><gtr:id>19638366913ccf65a0e6143096ef886e</gtr:id><gtr:otherNames>Teo H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>pm_12679_19_15469844</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D15BA967-A52A-4125-9C39-CC53D4168600</gtr:id><gtr:title>C2 domain conformational changes in phospholipase C-delta 1.</gtr:title><gtr:parentPublicationTitle>Nature structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38af4bc89f769bc32d374c823131ca2c"><gtr:id>38af4bc89f769bc32d374c823131ca2c</gtr:id><gtr:otherNames>Grobler JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1996-01-01</gtr:date><gtr:issn>1072-8368</gtr:issn><gtr:outcomeId>pm_12679_879_8784353</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06F6DF2B-290B-49B1-ABAA-E65D568F791B</gtr:id><gtr:title>Single-Molecule Study Reveals How Receptor and Ras Synergistically Activate PI3Ka and PIPSignaling.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fd30346e9afc87481168178eb6b1349"><gtr:id>4fd30346e9afc87481168178eb6b1349</gtr:id><gtr:otherNames>Buckles TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>5a9c24e3e6fd87.68210685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>745ACDD1-593F-4BFB-AD78-6D9B91C028B2</gtr:id><gtr:title>Structural and membrane binding analysis of the Phox homology domain of Bem1p: basis of phosphatidylinositol 4-phosphate specificity.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/724e49df8cff46ac62462ab618343d64"><gtr:id>724e49df8cff46ac62462ab618343d64</gtr:id><gtr:otherNames>Stahelin RV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>91681957328</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6E5795C-3ED4-49C4-B56C-018003CABF9B</gtr:id><gtr:title>Structures of PI4KIII? complexes show simultaneous recruitment of Rab11 and its effectors.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c65b62a487af132fc0d937764453fbe"><gtr:id>3c65b62a487af132fc0d937764453fbe</gtr:id><gtr:otherNames>Burke JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>545ca634ee75e3.82928772</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>802032A2-A8FC-4DE3-BD44-358BC2F9C118</gtr:id><gtr:title>The role of phosphoinositides and phosphorylation in regulation of NADPH oxidase.</gtr:title><gtr:parentPublicationTitle>Advances in enzyme regulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3492eb3c66c7abc5082d626ef7a92d73"><gtr:id>3492eb3c66c7abc5082d626ef7a92d73</gtr:id><gtr:otherNames>Perisic O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0065-2571</gtr:issn><gtr:outcomeId>pm_12679_19_15581496</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EB6A4D9-8305-4D11-B072-419E626A2DDE</gtr:id><gtr:title>The UBAP1 subunit of ESCRT-I interacts with ubiquitin via a SOUBA domain.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccc6e00645d6982afab2e48beee2007f"><gtr:id>ccc6e00645d6982afab2e48beee2007f</gtr:id><gtr:otherNames>Agromayor M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_12679_29_22405001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB349923-D71B-4038-894C-82179D6D531C</gtr:id><gtr:title>[Roles of ESCRT complexes in the MVB pathway].</gtr:title><gtr:parentPublicationTitle>Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45d02b56369c9790f9eb7eec81683613"><gtr:id>45d02b56369c9790f9eb7eec81683613</gtr:id><gtr:otherNames>Obita T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0039-9450</gtr:issn><gtr:outcomeId>pm_12679_29_21038590</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>905D64C8-DF20-4EA3-94F5-715C8E6F408B</gtr:id><gtr:title>5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d223776ba8849790f8ea3c2eb52755aa"><gtr:id>d223776ba8849790f8ea3c2eb52755aa</gtr:id><gtr:otherNames>Beaufils F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>5a9c252e4d0837.48598413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30DE0D60-0529-45D8-85DD-52B8D0F0B034</gtr:id><gtr:title>Structures of closed and open conformations of dimeric human ATM.</gtr:title><gtr:parentPublicationTitle>Science advances</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81ea4b7d79bc30e35cf90eb0329fe41b"><gtr:id>81ea4b7d79bc30e35cf90eb0329fe41b</gtr:id><gtr:otherNames>Baretic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2375-2548</gtr:issn><gtr:outcomeId>5a2fd21e88aad3.60731653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E622558-91AB-453C-AC8F-2779D65B5477</gtr:id><gtr:title>Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3492eb3c66c7abc5082d626ef7a92d73"><gtr:id>3492eb3c66c7abc5082d626ef7a92d73</gtr:id><gtr:otherNames>Perisic O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1998-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12679_979_9430701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EDAEEDE-C1FA-4277-B93C-AEC2D393DED8</gtr:id><gtr:title>An experiment regarding crystallization of soluble proteins in the presence of beta-octyl glucoside.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f330dc5ee7b3e936e7721bb795e40609"><gtr:id>f330dc5ee7b3e936e7721bb795e40609</gtr:id><gtr:otherNames>McPherson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1986-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12679_379_3944122</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>207895A6-B0A7-437E-A117-B97D6F1505C0</gtr:id><gtr:title>Structural insight into the ESCRT-I/-II link and its role in MVB trafficking.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07f1b1792355345b4d69d0eda4b425a1"><gtr:id>07f1b1792355345b4d69d0eda4b425a1</gtr:id><gtr:otherNames>Gill DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>90434C5684C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2EF050D-7B1C-455C-AFD3-5B5A3CAB4918</gtr:id><gtr:title>Mammalian phosphoinositide-specific phospholipase C.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/503bcc65a41fb82d61a7edfd9655d88a"><gtr:id>503bcc65a41fb82d61a7edfd9655d88a</gtr:id><gtr:otherNames>Williams RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_12679_19_10570253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F0B3766-680C-4ECE-A83F-01477BD69943</gtr:id><gtr:title>PKC? phosphorylates PI3K? to activate it and release it from GPCR control.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea75589477bd1395f091d2d54915cca9"><gtr:id>ea75589477bd1395f091d2d54915cca9</gtr:id><gtr:otherNames>Walser R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>pm_12679_29_23824069</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0749E577-7283-4AA5-BDD4-CEAF92E67FA6</gtr:id><gtr:title>The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8a9867184d5e624b6d8918e7df0f290"><gtr:id>f8a9867184d5e624b6d8918e7df0f290</gtr:id><gtr:otherNames>Berndt A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>NtDcJY9eG72</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A51478F-4D8B-43FE-AF71-98D82A0018B0</gtr:id><gtr:title>Structure and flexibility of the endosomal Vps34 complex reveals the basis of its function on membranes.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/611c61bc2043d4fa64d6cf9de39c763b"><gtr:id>611c61bc2043d4fa64d6cf9de39c763b</gtr:id><gtr:otherNames>Rostislavleva K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>56bdcfd8f20d26.60097060</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89713D29-B7BA-4750-821C-6D4BF842419E</gtr:id><gtr:title>Evolution and assembly of ESCRTs.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fac3124c7ba883bdfa239e77d45f6262"><gtr:id>fac3124c7ba883bdfa239e77d45f6262</gtr:id><gtr:otherNames>Ghazi-Tabatabai S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>8A1D1AC448A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BA65EEA-D28C-4FE9-A5EF-F196744904B8</gtr:id><gtr:title>A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61007779293ad4d44aa99cafde1d7458"><gtr:id>61007779293ad4d44aa99cafde1d7458</gtr:id><gtr:otherNames>Knight ZA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>1D1C881742F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96E77330-D65F-4563-B192-B03710492FA3</gtr:id><gtr:title>Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31ccd594fec792eb9422d669bb1a4261"><gtr:id>31ccd594fec792eb9422d669bb1a4261</gtr:id><gtr:otherNames>Pacold ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2000-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>pm_12679_19_11136978</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C11BF64-B729-4952-8D0A-932D131F0A5D</gtr:id><gtr:title>PTEN regulates cilia through Dishevelled.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e79a37ba23925334513cca62511806e4"><gtr:id>e79a37ba23925334513cca62511806e4</gtr:id><gtr:otherNames>Shnitsar I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56a8cf76847cd0.73395700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B85EADD-5A85-475B-8DE0-E2680DE55AC3</gtr:id><gtr:title>Phospholipase C delta 1 requires a pleckstrin homology domain for interaction with the plasma membrane.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f91dbffb718bd5f4019c6344bf5d7b1f"><gtr:id>f91dbffb718bd5f4019c6344bf5d7b1f</gtr:id><gtr:otherNames>Paterson HF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1995-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_12679_879_8554502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93EE1129-4DF5-4267-8DA1-5C285BEA1539</gtr:id><gtr:title>Structural and mutational analysis reveals that CTNNBL1 binds NLSs in a manner distinct from that of its closest armadillo-relative, karyopherin a.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38fd35398a4ccb9808bae821fd0c5d44"><gtr:id>38fd35398a4ccb9808bae821fd0c5d44</gtr:id><gtr:otherNames>Ganesh K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>544a453f406315.81699196</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E029D703-4812-4171-A50D-9B7DD1599EB7</gtr:id><gtr:title>Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFbeta.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83ccfdccfee9f5c568275cd5a6d39dd3"><gtr:id>83ccfdccfee9f5c568275cd5a6d39dd3</gtr:id><gtr:otherNames>Warren AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2000-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_12679_19_10856244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7D7E18A-9A05-4F75-A9BC-79245CC1FF93</gtr:id><gtr:title>The structural basis for mTOR function.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81ea4b7d79bc30e35cf90eb0329fe41b"><gtr:id>81ea4b7d79bc30e35cf90eb0329fe41b</gtr:id><gtr:otherNames>Baretic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn><gtr:outcomeId>544a43053f2494.86581019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8239AAD-5B1A-4467-8010-FF7026B91B41</gtr:id><gtr:title>Tyrosine residues in phospholipase Cgamma 2 essential for the enzyme function in B-cell signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6af67d9dcc83d7601dcf6c7310a019b4"><gtr:id>6af67d9dcc83d7601dcf6c7310a019b4</gtr:id><gtr:otherNames>Rodriguez R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12679_19_11606584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00079700-5BA9-4E09-8383-5FC64A348D4F</gtr:id><gtr:title>Structural insights into phosphoinositide 3-kinase catalysis and signalling.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88f2c3dd459e7ddcfdc9dd121eae9808"><gtr:id>88f2c3dd459e7ddcfdc9dd121eae9808</gtr:id><gtr:otherNames>Walker EH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_12679_19_10580505</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D637BE6D-7BBE-49F6-8447-9BF7B74333EB</gtr:id><gtr:title>Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone System.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec462cf530e0c2dddc2e98212b602d29"><gtr:id>ec462cf530e0c2dddc2e98212b602d29</gtr:id><gtr:otherNames>Bunney TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>5aa6807ebdd1f1.39907744</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BD51706-5952-4B86-800E-B9E3D7ABEC18</gtr:id><gtr:title>Using hydrogen deuterium exchange mass spectrometry to engineer optimized constructs for crystallization of protein complexes: Case study of PI4KIII? with Rab11.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99a9d2f016bd6ff7a7578b51a6feb2e0"><gtr:id>99a9d2f016bd6ff7a7578b51a6feb2e0</gtr:id><gtr:otherNames>Fowler ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>56a8ce3fdf0504.17806150</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F73B6A2C-8EC6-449E-9D2B-5378CBA426DD</gtr:id><gtr:title>Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110a (PIK3CA).</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c65b62a487af132fc0d937764453fbe"><gtr:id>3c65b62a487af132fc0d937764453fbe</gtr:id><gtr:otherNames>Burke JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12679_29_22949682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E8AB863-8A1E-4B7E-9479-C1AC99908557</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring autophagy.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>56bdd2c124c942.73623264</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3502D3A-77F6-4CE5-81C0-4C6D56E9E6D9</gtr:id><gtr:title>Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4abc40a0cff558ea8d19754b92495ad"><gtr:id>a4abc40a0cff558ea8d19754b92495ad</gtr:id><gtr:otherNames>de la Rosa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1995-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>pm_12679_779_7702594</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46339A49-F198-4F6B-833C-33B3B8B523ED</gtr:id><gtr:title>Kinases charging to the membrane.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ef589004c3149e1d085d244be7eb3d9"><gtr:id>3ef589004c3149e1d085d244be7eb3d9</gtr:id><gtr:otherNames>Hadders MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>SeshB4gkG58</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECC0941F-BBB2-427E-B6B6-38FBC3AD7B7B</gtr:id><gtr:title>Characterization of Atg38 and NRBF2, a fifth subunit of the autophagic Vps34/PIK3C3 complex.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e550cedc0981a774e7e4c1b3300448fd"><gtr:id>e550cedc0981a774e7e4c1b3300448fd</gtr:id><gtr:otherNames>Ohashi Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>58b5897e5581a2.86961344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C360CA1-EBD8-4D44-BC1E-49B3A0FF436C</gtr:id><gtr:title>Ragtime Regulation: Mechanism of TORC1 Activation in Nutrient Sensing.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/503bcc65a41fb82d61a7edfd9655d88a"><gtr:id>503bcc65a41fb82d61a7edfd9655d88a</gtr:id><gtr:otherNames>Williams RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>5a2fdc565f3183.86954752</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>746EF672-52AE-4C2A-A19E-825BCE993B7C</gtr:id><gtr:title>Crystal structure of a diabody, a bivalent antibody fragment.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3492eb3c66c7abc5082d626ef7a92d73"><gtr:id>3492eb3c66c7abc5082d626ef7a92d73</gtr:id><gtr:otherNames>Perisic O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1994-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_12679_779_7704531</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C683546-36D5-4938-9E30-8F0DD0A4BA77</gtr:id><gtr:title>Methods in the Study of PTEN Structure: X-Ray Crystallography and Hydrogen Deuterium Exchange Mass Spectrometry.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4aa8dc19bf3f675b800baccca8b1bdde"><gtr:id>4aa8dc19bf3f675b800baccca8b1bdde</gtr:id><gtr:otherNames>Masson GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>58b589b329f980.19858573</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF472D0F-7360-4201-9656-E1624EEF6992</gtr:id><gtr:title>Structural basis for activation and inhibition of class I phosphoinositide 3-kinases.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69b0fae08d9c261afa523bb5cab72351"><gtr:id>69b0fae08d9c261afa523bb5cab72351</gtr:id><gtr:otherNames>Vadas O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>NwxzRfMmREg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FD23B90-047E-40ED-968C-62FDEBFF720D</gtr:id><gtr:title>Structure of a human inositol 1,4,5-trisphosphate 3-kinase: substrate binding reveals why it is not a phosphoinositide 3-kinase.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/741cefa59bf30770365b80ddc029bed0"><gtr:id>741cefa59bf30770365b80ddc029bed0</gtr:id><gtr:otherNames>Gonz?lez B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_12679_19_15350214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4AF3D5A-A59B-445F-801C-5C54B4B5EB3B</gtr:id><gtr:title>The intrinsically disordered tails of PTEN and PTEN-L have distinct roles in regulating substrate specificity and membrane activity.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4aa8dc19bf3f675b800baccca8b1bdde"><gtr:id>4aa8dc19bf3f675b800baccca8b1bdde</gtr:id><gtr:otherNames>Masson GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>56a8cef1330a84.72763469</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E98096FD-B1DB-4D6F-BF6F-7864274C052C</gtr:id><gtr:title>PI3K? downstream of GPCRs - crucial partners in oncogenesis.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2162d2030d61d9ec33add4bd0e71eb72"><gtr:id>2162d2030d61d9ec33add4bd0e71eb72</gtr:id><gtr:otherNames>Dbouk HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>56bdd1444ff2b3.42353513</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3359DE5-C025-4252-B450-B040DDA2CD82</gtr:id><gtr:title>Phosphoinositide 3-kinase d gene mutation predisposes to respiratory infection and airway damage.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28a5d405946584af030b04daeee4c67d"><gtr:id>28a5d405946584af030b04daeee4c67d</gtr:id><gtr:otherNames>Angulo I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_12679_29_24136356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A74B6EB-9D9C-4716-A74E-052B40A648B7</gtr:id><gtr:title>The crystal structure of a human nucleoside diphosphate kinase, NM23-H2.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dcab3ac7e59cbcd694096e73e972b75"><gtr:id>4dcab3ac7e59cbcd694096e73e972b75</gtr:id><gtr:otherNames>Webb PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1995-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pm_12679_779_7658474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40EFAF93-17E0-452B-AC56-4818884AD40F</gtr:id><gtr:title>Structural insights into endosomal sorting complex required for transport (ESCRT-I) recognition of ubiquitinated proteins.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19638366913ccf65a0e6143096ef886e"><gtr:id>19638366913ccf65a0e6143096ef886e</gtr:id><gtr:otherNames>Teo H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12679_19_15044434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC31B99B-5035-4AEE-A2EF-FF7644259902</gtr:id><gtr:title>Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9280b9f441ca1d50b85d73905fa208a8"><gtr:id>9280b9f441ca1d50b85d73905fa208a8</gtr:id><gtr:otherNames>Tanaka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>94831A22ECC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>056E09CC-5220-492B-8C53-2FFAE433E619</gtr:id><gtr:title>Dynamic steps in receptor tyrosine kinase mediated activation of class IA phosphoinositide 3-kinases (PI3K) captured by H/D exchange (HDX-MS).</gtr:title><gtr:parentPublicationTitle>Advances in biological regulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c65b62a487af132fc0d937764453fbe"><gtr:id>3c65b62a487af132fc0d937764453fbe</gtr:id><gtr:otherNames>Burke JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2212-4926</gtr:issn><gtr:outcomeId>aZBddoizDkW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AAE76DE-CAF9-42EF-878A-45C43C6BFF71</gtr:id><gtr:title>Structural basis for Arl1-dependent targeting of homodimeric GRIP domains to the Golgi apparatus.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6db3c2412b44d262106d72e7c0d38be6"><gtr:id>6db3c2412b44d262106d72e7c0d38be6</gtr:id><gtr:otherNames>Panic B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_12679_19_14580338</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9DA8A26-7EEC-461C-BDC7-6A05A612FB50</gtr:id><gtr:title>Structural basis for the interaction of [E160A-E189A]-trichosanthin with adenine.</gtr:title><gtr:parentPublicationTitle>Toxicon : official journal of the International Society on Toxinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c4b622374e781fef0a30219e7a7361b"><gtr:id>7c4b622374e781fef0a30219e7a7361b</gtr:id><gtr:otherNames>Shaw PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0041-0101</gtr:issn><gtr:outcomeId>pm_12679_19_12676436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAAF1AA5-3302-412C-B4A9-973EAC5EF883</gtr:id><gtr:title>The p110delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8a9867184d5e624b6d8918e7df0f290"><gtr:id>f8a9867184d5e624b6d8918e7df0f290</gtr:id><gtr:otherNames>Berndt A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>pm_12679_29_20154668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A99FD969-D14D-445D-AB4D-680473AF0643</gtr:id><gtr:title>Analysis of phosphoinositide 3-kinase inhibitors by bottom-up electron-transfer dissociation hydrogen/deuterium exchange mass spectrometry.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4aa8dc19bf3f675b800baccca8b1bdde"><gtr:id>4aa8dc19bf3f675b800baccca8b1bdde</gtr:id><gtr:otherNames>Masson GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5a3616958f9df0.33609145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C39C59C1-D5B9-4728-9DCA-0FC2BA8318D9</gtr:id><gtr:title>Structure of lipid kinase p110?/p85? elucidates an unusual SH2-domain-mediated inhibitory mechanism.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0d10ae0b5fee7f7d7a790e1b961f1e4"><gtr:id>f0d10ae0b5fee7f7d7a790e1b961f1e4</gtr:id><gtr:otherNames>Zhang X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>NaKsfyahNfe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30EEA500-7BBA-497D-A471-3BFFF25AECB8</gtr:id><gtr:title>Structural Insights into Arl1-Mediated Targeting of the Arf-GEF BIG1 to the trans-Golgi.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f36777822ce707871c76bc6582a06c0"><gtr:id>8f36777822ce707871c76bc6582a06c0</gtr:id><gtr:otherNames>Galindo A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d6b5e4a3eb4.99552060</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4B6A880-AAC0-4A01-9C59-16ACD045FA08</gtr:id><gtr:title>Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/232b397aab5a9006ee998b67ebf1922c"><gtr:id>232b397aab5a9006ee998b67ebf1922c</gtr:id><gtr:otherNames>Hon WC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>qG9WZ4up5r1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24F38638-51CC-41D2-BF5B-71C2A1883552</gtr:id><gtr:title>Connecting with an old partner in a new way.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c65b62a487af132fc0d937764453fbe"><gtr:id>3c65b62a487af132fc0d937764453fbe</gtr:id><gtr:otherNames>Burke JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>pm_12679_29_23680139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CBB101F-5D45-4E71-A4D3-F574C9F4B2D0</gtr:id><gtr:title>Crystal structure of the two N-terminal domains of g3p from filamentous phage fd at 1.9 A: evidence for conformational lability.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d8dc57afcc02600707257783872e92c"><gtr:id>1d8dc57afcc02600707257783872e92c</gtr:id><gtr:otherNames>Holliger P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pm_12679_19_10329170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D4CA68E-0858-4F40-898E-39D5A927BB6D</gtr:id><gtr:title>Crystal structure of Myxococcus xanthus nucleoside diphosphate kinase and its interaction with a nucleotide substrate at 2.0 A resolution.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/503bcc65a41fb82d61a7edfd9655d88a"><gtr:id>503bcc65a41fb82d61a7edfd9655d88a</gtr:id><gtr:otherNames>Williams RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1993-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pm_12679_879_8263923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEBEDD66-E0C3-45C9-A854-CB037B9F43B7</gtr:id><gtr:title>The structural basis of novel endosome anchoring activity of KIF16B kinesin.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3100561ed719cb3e6e0cca056c558314"><gtr:id>3100561ed719cb3e6e0cca056c558314</gtr:id><gtr:otherNames>Blatner NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>D91A69E5065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94E3E574-F3AE-4E57-BA8F-0F12FC926DF3</gtr:id><gtr:title>Membrane trafficking: Arls squeeze the fat out.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/503bcc65a41fb82d61a7edfd9655d88a"><gtr:id>503bcc65a41fb82d61a7edfd9655d88a</gtr:id><gtr:otherNames>Williams RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>MYbhyyL9py8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEFD115A-F66F-42E1-80D2-A9384E37BDA0</gtr:id><gtr:title>Tor forms a dimer through an N-terminal helical solenoid with a complex topology.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81ea4b7d79bc30e35cf90eb0329fe41b"><gtr:id>81ea4b7d79bc30e35cf90eb0329fe41b</gtr:id><gtr:otherNames>Baretic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58b58abc3722b7.11186957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A120541A-4B9C-4E9E-A505-27A89F698AC6</gtr:id><gtr:title>A role for the ESCRT system in cell division in archaea.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c757ef1f77eb83d0ae49eca1ee8d6c9"><gtr:id>0c757ef1f77eb83d0ae49eca1ee8d6c9</gtr:id><gtr:otherNames>Samson RY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>63D6449F3A9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAACF295-974B-4A5B-A8B6-C13E67C4A7AC</gtr:id><gtr:title>Molecular determinants of PI3K?-mediated activation downstream of G-protein-coupled receptors (GPCRs).</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69b0fae08d9c261afa523bb5cab72351"><gtr:id>69b0fae08d9c261afa523bb5cab72351</gtr:id><gtr:otherNames>Vadas O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>544a45966e56c6.28351640</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9C8F04C-F26F-4E0F-98B5-C122742381C1</gtr:id><gtr:title>The emerging shape of the ESCRT machinery.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/503bcc65a41fb82d61a7edfd9655d88a"><gtr:id>503bcc65a41fb82d61a7edfd9655d88a</gtr:id><gtr:otherNames>Williams RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>F00FF03E664</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AA0B18F-ABE6-4413-B8FA-43E352EAABE1</gtr:id><gtr:title>Form and flexibility in phosphoinositide 3-kinases.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6682b85c220c8c8bd534e7066c4856a9"><gtr:id>6682b85c220c8c8bd534e7066c4856a9</gtr:id><gtr:otherNames>Williams R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>14B5A50D40F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B246BC9-639C-4330-8017-514BB13EF978</gtr:id><gtr:title>G protein-coupled receptor-mediated activation of p110? by G?? is required for cellular transformation and invasiveness.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2162d2030d61d9ec33add4bd0e71eb72"><gtr:id>2162d2030d61d9ec33add4bd0e71eb72</gtr:id><gtr:otherNames>Dbouk HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>oiWqdQaJdM6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8221837E-432D-4157-BB62-8F29155B9E1A</gtr:id><gtr:title>The crystal structure of the PX domain from p40(phox) bound to phosphatidylinositol 3-phosphate.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a5046b1b8a20af840e1a9eb4de93433"><gtr:id>2a5046b1b8a20af840e1a9eb4de93433</gtr:id><gtr:otherNames>Bravo J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_12679_19_11684018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B70BFF5C-02B9-4AD0-AF78-8B4CE4F6939D</gtr:id><gtr:title>Structural and membrane binding analysis of the Phox homology domain of phosphoinositide 3-kinase-C2alpha.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/724e49df8cff46ac62462ab618343d64"><gtr:id>724e49df8cff46ac62462ab618343d64</gtr:id><gtr:otherNames>Stahelin RV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>FCCD0D62A28</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34E8AB0F-3EE3-4CD2-BA99-654933348823</gtr:id><gtr:title>GLABRA2 Directly Suppresses Basic Helix-Loop-Helix Transcription Factor Genes with Diverse Functions in Root Hair Development.</gtr:title><gtr:parentPublicationTitle>The Plant cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7b7e0d238592f579e1058517d4ed7f6"><gtr:id>c7b7e0d238592f579e1058517d4ed7f6</gtr:id><gtr:otherNames>Lin Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1040-4651</gtr:issn><gtr:outcomeId>5a324b5ac018e5.45388136</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45F5D437-8D22-4B9F-9752-E2DD732C0F66</gtr:id><gtr:title>A ternary metal binding site in the C2 domain of phosphoinositide-specific phospholipase C-delta1.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e4907cc520007b00ff1255ae9415d22"><gtr:id>7e4907cc520007b00ff1255ae9415d22</gtr:id><gtr:otherNames>Essen LO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1997-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>pm_12679_979_9062102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0189F326-6250-4344-85E4-5BDD5241AEF1</gtr:id><gtr:title>An overview of hydrogen deuterium exchange mass spectrometry (HDX-MS) in drug discovery.</gtr:title><gtr:parentPublicationTitle>Expert opinion on drug discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4aa8dc19bf3f675b800baccca8b1bdde"><gtr:id>4aa8dc19bf3f675b800baccca8b1bdde</gtr:id><gtr:otherNames>Masson GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1746-0441</gtr:issn><gtr:outcomeId>5a2fd8a2908919.35316421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4912385-D2B1-4340-A3B8-B34BAA80D0D5</gtr:id><gtr:title>ESCRT-I core and ESCRT-II GLUE domain structures reveal role for GLUE in linking to ESCRT-I and membranes.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19638366913ccf65a0e6143096ef886e"><gtr:id>19638366913ccf65a0e6143096ef886e</gtr:id><gtr:otherNames>Teo H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>3064237BD9E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D9A3F81-CE5D-4CD1-9231-46804CD38605</gtr:id><gtr:title>Identification of a Potent Phosphoinositide 3-Kinase Pan Inhibitor Displaying a Strategic Carboxylic Acid Group and Development of Its Prodrugs.</gtr:title><gtr:parentPublicationTitle>ChemMedChem</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/202b9b1cf0fb8ac157d2ca95241ecbeb"><gtr:id>202b9b1cf0fb8ac157d2ca95241ecbeb</gtr:id><gtr:otherNames>Pirali T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1860-7179</gtr:issn><gtr:outcomeId>5a9c250a8ed6a5.74983644</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB9AFBB5-AB7D-49B1-8CC6-444C463F4843</gtr:id><gtr:title>Different inhibition of G??-stimulated class IB phosphoinositide 3-kinase (PI3K) variants by a monoclonal antibody. Specific function of p101 as a G??-dependent regulator of PI3K? enzymatic activity.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a16ae2aa9c3df4a9325b2accedbacfa"><gtr:id>7a16ae2aa9c3df4a9325b2accedbacfa</gtr:id><gtr:otherNames>Shymanets A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>56bdd0262d26a9.97520131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B4A7830-2BD6-469D-BE3D-F44AFE47EC78</gtr:id><gtr:title>Calcium-dependent membrane penetration is a hallmark of the C2 domain of cytosolic phospholipase A2 whereas the C2A domain of synaptotagmin binds membranes electrostatically.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc557bc312a085ddea41a9a0ec865646"><gtr:id>bc557bc312a085ddea41a9a0ec865646</gtr:id><gtr:otherNames>Davletov B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1998-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12679_979_9668093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F21A6DAD-218D-4686-9854-FF71ABD2190A</gtr:id><gtr:title>Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c23cb0ac2d9810021d2c280ea06e209"><gtr:id>2c23cb0ac2d9810021d2c280ea06e209</gtr:id><gtr:otherNames>Apsel B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>965176538E4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0618C04-8AFA-4017-B0E6-2AE8F4735B49</gtr:id><gtr:title>Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88f2c3dd459e7ddcfdc9dd121eae9808"><gtr:id>88f2c3dd459e7ddcfdc9dd121eae9808</gtr:id><gtr:otherNames>Walker EH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2000-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_12679_19_11090628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11EC36FF-ED36-44F4-AE59-9A1639C55AE3</gtr:id><gtr:title>Crystal structure of a mammalian phosphoinositide-specific phospholipase C delta.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e4907cc520007b00ff1255ae9415d22"><gtr:id>7e4907cc520007b00ff1255ae9415d22</gtr:id><gtr:otherNames>Essen LO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1996-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_12679_879_8602259</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105184308</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>